190results about How to "Total effective rate is high" patented technology

The invention relates to a medicine for treating schizophrenia, relating to a medicine composition for treating schizophrenia, in particular to a medicine for treating schizophrenia by using fossil, ore, Chinese animal medicine and Chinese herbal medicines as raw materials. The formula comprises the following components: raw keel, ochre, rhubarb, wrinkled gianthyssop, tabasheer, lapis chloriti, arisaema with bile, albizia bark, datura flower, japanese sweetflag, radix curcumae, radix bupleuri, eupatorium, burreed tuber, curcuma zedoary, poria with hostwood and magnet. The medicine has therapeutic effects on schizophrenia, is safe and effective, has quick effect-taking, high total effective rate, few side effects and low recurernce rate when matched with a low dose of antipsychotic for treating schizophrenia, and is low in price, convenient to carry and take, and especially suitable for long-term maintenance treatment in a recovery phase and a stable phase.

The invention discloses a medicine for treating haemorrhoids, and belongs to the technical field of traditional Chinese medicines. The medicine is prepared from the following raw materials: 5-15 g of scutellaria baicalensis, 5-15 g of angelica sinensis, 5-15 g of dried orange peel, 5-15 g of rheum officinale, 5-15 g of gallnut, 5-15 g of pangolin, 5-15 g of peach kernel, 10-20 g of Codonopsis pilosula, 10-20 g of unprepared rehmannia, 10-20 g of Radix Ophiopogonis, 10-20 g of white atractylodes rhizome, 10-20 g of radix bupleuri, 10-20 g of sophora flower, 10-20 g of sophora fruit, 15-25 g of golden cypress, 15-25 g of astragalus membranaceus, 5-10 g of cimicifugae foetidae, 5-10 g of fructus aurantii and 2-5 g of liquorice. The medicine has the effects of clearing away heat and cooling blood, prompting dampness removal and detoxification, softening hard lumps, removing swelling and stopping pains, can treat both symptoms and root causes, and has no toxic or side effects; when the medicine is used for treating 80 patients suffering from the haemorrhoids, the medicine completely cures 62 patients, has a certain effect on 10 patients and is effective for 6 patients; the medicine has the total effective rate as high as 97.5% and has no toxic or side effects.

A Chinese medicine in the form of powder for treating gastric ulcer and duodenal ulcer is prepared through decocting astragalus root, white peony root and liquorice root, filtering, concentrating, depositing in alcohol, distilling to remove alcohol, concentrating, mixing with cuttlefish bone powder and famotidine, drying and pulverizing. Its advantages are high cure rate and low cost.

The invention discloses a medicine for treating postpartum abdominal pain and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The medicine comprises effective composition raw materials as follows: schefflera arboricola hayata, lycopus root, bellflower, olibanum, celastrus gemmatus loes, curious kadsura root or stem, lycopus lucidus, crataegus, typha pollen, root of David currant, Japanese raspberry, leonurus macranthus maxim, herb of ghostplant wormwood, crape myrtle root, shouliang yam rhizome and bark of corkywing euonymus. The medicine has the efficacy of replenishing blood and activating blood, warming the channels to relieve pain, promoting the circulation of qi, dissipating stasis, and dispelling toxin and eliminating dampness, has the remarkable curative effect on the postpartum abdominal pain, is safe and reliable, has no any toxic or side effects, can restrain the postpartum abdominal pain, has the active effect on boosting women's health. Clinic test results show that the total efficiency of medicine for the treatment of patients suffering from the postpartum abdominal pain reaches 96.9 percent, and the medicine is worth of widely popularizing and applying.

The invention relates to a medicine for treating insomnia. Raw materials of the medicine comprise, by weight, 20 parts of Flos Albiziae, 20 parts of Angelica sinensis, 18 parts of Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 12 parts of Ramulus Cinnamomi, 12 parts of Ligusticum chuanxiong Hort, 15 parts of Radix Scrophulariae, 9 parts of Radix astragali, 10 parts of Anemarrhena asphodeloides, 8 parts of seed of wild jujube, 8 parts of Pinellia ternate, 9 parts of Rhizoma cyperi, 7 parts of rhizoma coptidis, 7 parts of Poria cocos and 5 parts of semen cassiae. It has been clinically verified that the medicinal composite for treating insomnia has efficacy of treating insomnia, is nontoxic and harmless to human body, can be used to treat both principal and secondary aspect of disease, has no side effect, is low-priced, is simple to prepare, and has an extensive application prospect.

The invention relates to a Chinese medicine composition for treating insomnia and dreamful sleep, comprising the following raw materials in parts by weight: 30 parts of unprocessed rehmannia root, 20 parts of flower of silktree, 18 parts of codonopsis pilosula, 15 parts of dwarf lilyturf root, 12 parts of achyranthes bidentata, 15 parts of radix scrophulariae, 10 parts of red-rooted salvia root, 10 parts of vine of multiflower knotweed, 9 parts of astragalus mongholicus, 9 parts of glossy privet fruit, 8 parts of spina date seed, 8 parts of pinellia ternate, 9 parts of Chinese yam, 7 parts ofkudzuvine root, 8 parts of liquorice root and 5 parts of poria cocos. The clinic verification proves that the Chinese medicine composition for treating insomnia and dreamful sleep has efficacy on curing insomnia, is nontoxic and harmless to the human body, treats both manifestation and root cause, has the characteristics of no side effect, low cost, wide application prospect and convenience for manufacture.

The invention relates to the technical field of traditional Chinese medicines, and especially relates to a traditional Chinese medicinal composition for treating seasonal allergic rhinitis. The traditional Chinese medicinal composition for treating seasonal allergic rhinitis is prepared by using the following medicinal materials, by weight, 10-15 parts of Blackberrylily Rhizome, 10-15 parts of apricot kernel, 4-8 parts of Radix Platycodonis, 10-15 parts of Aster tataricus, 10-15 parts of Common Coltsfoot Flower, 10-15 parts of (fried) lumbricus, 8-13 parts of gingko, 4-8 parts of Divaricate Saposhnikovia Root, 6-11 parts of cassia twig, 10-15 parts of white peony root, 6-11 parts of Chinese angelica, 6-11 parts of licorice root, 8-13 parts of Negundo Chastetree Fruit, 12-18 parts of perilla fruit, 6-11 parts of lily, 10-15 parts of Polygonatum sibiricum, 10-15 parts of Herba Centipedae, 12-18 parts of Manchurian wildginger, 6-11 parts of Rhizoma Anemarrhenae, 10-15 parts of datura flower and 12-18 parts of Chinese ilex. The composition is mainly used for treating the seasonal allergic rhinitis, especially progressive seasonal allergic rhinitis difficult to cure clinically; and years of clinic application researches show that the total effective rate of the composition on asthmatic suffocating caused by the seasonal allergic rhinitis, seasonal aggravated rhinitis and allergic trachitis can reach 100%.

The invention relates to a pantoprazole sodium medicine compound and a preparation technology thereof. The pantoprazole sodium medicine compound is prepared by taking the following raw materials by weight part: 0.5 parts of pantoprazole sodium, 35 parts of astragalus mongholicus, 27 parts of mangnolia officinalis, 18 parts of pinellia ternata and 15 parts of curcuma zedoary. According to the traditional medicine preparation method, after pharmaceutic adjuvants, such as starch or edible cellulose, are added, the medicine is prepared into capsules, tablets, grains, and the like. The pantoprazole sodium medicine compound provided by the invention has the function of treating both principal and secondary aspects of gastric ulcer, is non-toxic and harmless to human body, is free from side effect, is low in cost, is conveniently prepared and is wide in application prospect.

The invention relates to a traditional Chinese medicine extract for treating diabetes. The traditional Chinese medicine extract is prepared from the following crude drugs of 8 to 12 parts of rhizoma polygonati, 8 to 12 parts of radix astragali seu hedysari, 6 to 10 parts of radix panacis quinquefolii, 8 to 12 parts of radix ophiopogonis, 18 to 22 parts of rhizoma dioscoreae, 8 to 12 parts of pueraria mirifica, 8 to 12 parts of bitter gourd, 6 to 10 parts of fructus lycii, 6 to 10 parts of rhizoma polygonati odorati, 8 to 12 parts of fructus cormi, 6 to 10 parts of mulberry fruit, 6 to 10 partsof ramuli euonymi, 8 to 12 parts of herba epimedii, 6 to 10 parts of radix rehmanniae recen, 6 to 10 parts of radix rehmanniae praeparata, 6 to 10 parts of semen cassiae, 4 to 6 parts of semen cuscutae, 2 to 4 parts of cortex cinnamomi, 6 to 8 parts of radix trichosanthis, 8 to 12 parts of cortexlycii radicis, 4 to 6 parts of banana, 8 to 12 parts of grape peel, and 8 to 12 parts of grape seed. The invention also relates to a preparation method and application of the traditional Chinese medicine extract for treating diabetes. The traditional Chinese medicine extract has the advantages that the effects of invigorating Qi and nourishing Yin as well as promoting body fluid production and relieving thirst are realized; proofed by clinical application, the good treatment function is realized on the diabetes.

The invention relates to novel application of notoginseng, notoginseng extract, panax notoginseng saponins and a panax notoginseng saponins composition, namely, novel application in preparing medicaments for treating and/or preventing coronary artherosclerosis.

The invention relates to a traditional Chinese medicine for treating respiratory tract infection and a preparation method of the traditional Chinese medicine. The traditional Chinese medicine comprises talc, herba artemisiae scopariae, fried scutellaria baicalensis, dichanthelium, processed rhizoma pinelliae, processed cortex magnoliae officinalis, radix angelicae, common hogfennel roots, agastache rugosa, fried almonds and salviae miltiorrhizae. The traditional Chinese medicine can effectively and safely treat the respiratory tract infection, the total effective rate is greatly improved, the course of disease is shortened, the morbidity and the recurrent rate of the respiratory tract infection are greatly reduced, the human body immunity is improved, the damage caused by antibiotics to the human body is reduced to the maximum extent, abuse of antibiotics is avoided, and the aim of simultaneous treatment of principal and subordinate symptoms is achieved.

The present invention provides a new crystal form of mianserin hydrochloride, a detection method and applications, and relates to a traditional Chinese medicine and Western medicine preparation for depression, especially to applications of a compound drug prepared from a Western medicine mianserin hydrochloride adopted as the main component and Chinese herbs in treatment of depression. According to the mianserin hydrochloride, benzaldehyde and ethanolamine are adopted as starting raw materials and are subjected to chemical combination to obtain an intermediate I, the intermediate I reacts with styrene oxide to obtain an intermediate II, the intermediate II and thionyl chloride are subjected to chemical combination under an alkaline condition to obtain an intermediate III, the intermediate III, o-aminobenzyl alcohol and fumaric acid are subjected to chemical combination to obtain an intermediate IV, an intermediate V is obtained from the intermediate IV under the action of concentrated sulfuric acid and sodium carbonate, the intermediate V reacts with ethyl chloroformate under an alkaline condition to obtain an intermediate VI, the intermediate VI reacts with formaldehyde and formic acid to obtain an intermediate VII, and the intermediate VII is acidified with hydrochloric acid-ethyl acetate to obtain the mianserin hydrochloride. The new crystal form of the mianserin hydrochloride of the present invention has characteristics of significant treatment effect, symptom and root cause treatment, and wide application prospets.

The invention relates to a medicinal composition for treating type II diabetes mellitus. The medicinal composition is prepared from the following raw materials in parts by weight: 18-22 parts of dwarf lilyturf root, 16-20 parts of baikal skullcap root, 16-20 parts of Chinese yam, 14-18 parts of Chinese angelica, 14-17 parts of common anemarrhena, 10-14 parts of polished round-grained rice, 10-14 parts of liquoric root, 8-12 parts of astragalus, 9-11 parts of large-head atractylodes rhizome, 7-9 parts of white paeony root, 6-8 parts of dark plum fruit, 5-7 parts of kudzuvine root, 5-7 parts ofprepared rehmannia, 3-5 parts of Chinese magnoliavine fruit and 3-5 parts of ginseng. The medicinal composition has the advantages of short treatment course, high total effective rate, prevention of relapse after curing, simple process, reduction in production cost and lowering of the economic burden of a patient.

The invention relates to a traditional Chinese medicine composition for treating neurasthenia. The traditional Chinese medicine composition is prepared by the following raw materials: radix polygonati officinalis, the root of red-rooted salvia, jasmine, dandelion, polygala tenuifolia, schisandra chinensis, poria cocos, Chinese parsnip root, smoked plum, dogwood, radix ophiopogonis, glossy privet fruit, bidens, herba epimedii, humifuse euphorbia herb, mulberry fruit, radix curcumae, radix stemonae, uncaria, dendrobe, caulis bambusae in taeniam, trichosanthes kirilowii Maxim, ginger, radix paeoniae alba, ligusticum wallichii, semen cassia and cassia twig. The traditional Chinese medicine composition is formed to be capsules, tablets, granules and other dosage forms according to a usual pharmacy method. The traditional Chinese medicine preparation can treat both manifestation and root cause of neurasthenia, has no toxic and side effects to human body, is low in cost and easy and convenient to prepare, and has wide application prospect.

The invention discloses a traditional Chinese medicine composition for treating soft tissue injury and fracture. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 30 parts of garden balsam stem, 28 parts of safflower, 26 parts of ligusticum wallichii, 25 parts of great burdock leaf, 25 parts of drynaria, 22 parts of lamiophlomis rotate, 22 parts of lycopodium clavatum, 20 parts of radix salviae miltiorrhizae, 20 parts of peach kernel, 18 parts of rhizoma corydalis, 18 parts of licorice, 18 parts of pawpaw, 16 parts of folium mori, 14 parts of radix achyranthis bidentatae, 12 parts of artemisia anomala, 10 parts of japanese tripterospermum herb, 9 parts of angelica, 8 parts of astragalus root, 8 parts of rhizoma atractylodis, 7 parts of platycodon grandiflorum, 5 parts of eupolyphaga, 5 parts of earthworm and 3 parts of cicada slough. The traditional Chinese medicine composition disclosed by the invention is remarkable in curative effect and free of toxic side effect, thereby having a good application prospect.

The invention discloses a medicinal Chinese medicine for curing regenerative obstructive anaemia and its preparing technique, prepared in proportion of red ginseng tails, Radix astragali, Radix rehmanniae preparata, dodder seed, alter slice, moxibustion tortoise plastron, medlar, Malaytea Scurfpea Fruit, Prepared Common Monkshood Daughter Root, and cinnamon. And the preparing technique: decocting the above ten raw materials twice and combining the two filtrates; then concentrating, alcohol-depositing, cooling to room temperature and making into cream; drying the cream and then making powder spraying and filling into capsules; or adding dextrin or starch to the cream to make into soft material, and finally screening and drying the soft material to make into electuary or tablets. It can not only regulate mediation disorder of human immunity, stimulate the hemopoiesis recovery of human marrow, and have remarkable curative effect on the regenerative obstructive anaemia but also has considerably good curative effect on other refractory anaemias, as well as the symptoms caused by various reasons, such as marrow inhibition, blood cell reduction, etc. And it almost has no toxicity and side effect, safe and reliable, low-cost.

The invention provides a traditional Chinese medicine composition for treating bradyarrhythmia, which comprises the following raw material medicine in weight percentage: 20-40 parts of Chinese ephedra, 2-4 parts of cassia twig, 1-3 parts of magnolia vine fruit, 15-25 parts of aconite root, 10-20 parts of dried rehmannia root, 5-15 parts of astragalus root, 2-6 parts of asarum herb, 10-20 parts of lilyturf root and 4-8 parts of prepared licorice root. The invention also provides an application of the traditional Chinese medicine composition in the treatment of bradyarrhythmia, particularly in the treatment of sick sinus syndrome and atrioventricular block. The clinical test and animal test show that the traditional Chinese medicine composition has high total effective rate of treating the bradyarrhythmia, works better than the isoprenaline, and has the remarkable significance in treatment of sick sinus syndrome and atrioventricular block; meanwhile, the acute toxicity test shows that the traditional Chinese medicine composition is extremely low in toxicity, thereby being easy to be accepted by patients; and additionally, the traditional Chinese medicine composition is less in components of the raw material medicine, rich, easily obtained, low in price, simple in preparation process, and suitable for universal popularization and application.

The invention discloses a traditional Chinese medicine for curing goose teniasis, which comprises the following materials: 25 to 45 parts of coptis chinensis, 30 to 45 parts of scutellaria, 30 to 45 parts of cortex phellodendri, 30 to 45 parts of Chinese pulsatilla root, 35 to 50 parts of radix sophorae flavescentis, 30 to 50 parts of gentian, 25 to 35 parts of curcuma aromatica, 25 to 45 parts of liquorice, 25 to 35 parts of betelnut, 30 to 45 parts of semen pharbitidis and 30 to 40 parts of hawthorn. The traditional Chinese medicine is high in worm discharging speed, large in worm discharging quantity and complete in worm discharging efficiency for curing goose teniasis. The curative effect in obvious; the total effective rate is up to 88%; compared with control groups, the curative effect and the total effective rate are greatly improved. The traditional Chinese medicine is wide in sources, lower in cost and convenient to prepare.

The invention discloses an external use compound Chinese herbal preparation for treating ankylosing spondylitis and a preparation method thereof. The Chinese herbal preparation consists of the following constituents in parts by weight: radix aconite, kusnezoff monkshood root, achyranthes bidentata, radix angelicae pubescentis, rhizoma chuanxiong, carthamus tinctorius, gentiana macrophylla, obscured homalomenarhizome, caulis spatholobi, common clubmoss herb and radix glycyrrhizae. The Chinese herbal preparation can be soaked in white spirit or medicinal alcohol to prepare traditional Chinese medicine wine, can also be directly blended with the white spirit or the medical alcohol into pasty external application medicine, and can further be decocted with water to prepare traditional Chinese medicine liquid. According to the external use compound Chinese herbal preparation for treating the ankylosing spondylitis and the preparation method thereof, the Chinese herbal preparation has the excellent characteristics of being high in cure rate, definite and reasonable in therapeutic effect, quick in effect, shorter in treatment course, safe, free of side effects, lower in expense and the like, and moreover can treat the symptoms and the causes of the ankylosing spondylitis; the preparation method of the Chinese herbal preparation is various, simple and convenient, and different pharmaceutical forms can be used for different therapy ways, so that the therapy effects can be greatly improved.

The invention belongs to the technical field of medicine and discloses a Chinese medicinal preparation for treating recurrent oral ulceration. The Chinese medicinal preparation for treating recurrent oral ulceration is prepared from the following raw materials: 20 parts of natural indigo, 18 parts of sessile stemona root, 15 parts of humifuse euphorbia herb, 15 parts of curcuma zedoaria, 12 parts of snake gourd fruit, 12 parts of barbed skullcap herb, 12 parts of amur cork tree bark, 10 parts of platycodon grandiflorus, 10 parts of gardenia, 10 parts of liquorice, 10 parts of astragalus, 10 parts of ophiopogon japonicus, 7 parts of dark plum fruit, 7 parts of prunella vulgaris, 5 parts of cortex albiziae, 5 parts of muskmelon seed, 5 parts of uncaria tomentosa and 3 parts of mulberry leaf. The Chinese medicinal preparation disclosed by the invention has a short treatment course for treating recurrent oral ulceration and has a high total effective rate; after the Chinese medicinal preparation is applied and recurrent oral ulceration is healed, recurrent oral ulceration is difficult to recur moreover, the process is simple, the production cost is reduced and the economical burden of a patient is reduced.

The invention relates to a Chinese medicinal preparation for treating early diabetic nephropathy and a preparation method thereof, and aims to provide a Chinese medicinal preparation which has an obvious curative effect, low cost, high tolerance and high patient compliance and is safe and reliable and used for treating the early diabetic nephropathy. The Chinese medicinal preparation for treating the early diabetic nephropathy comprises astragalus, leech and coix root. The Chinese medicinal preparation can improve the function of kidney, inhibit the activating proliferation of kidney tissue fibroblasts and regulate the release function of inflammation media under the action of tonifying qi, invigorating blood circulation and inducing diuresis, so that pathological links of glomeruli and interstitial fibrosis are blocked by ways of regulating and controlling biological effects of the glomeruli and interstitial cells and the like to prevent and treat renal fibrosis and delay the progress of kidney pathology. Compared with single Chinese patent medicaments, the Chinese medicinal preparation has the characteristics of no obvious toxic or side effect and obvious effects of improving the kidney function and reducing urine protein, and is safe in use.

The invention relates to a concentrated oral solution for treating recurrent oral ulcer by type of fire excess from yin deficiency, which can be used for effectively solving the problems of poor curative effect, hard healing, long treatment cycle, high side effect, more impurities, low extract utilization, low content of effective components, poor administration effect and inconvenience in carrying. The oral solution is prepared from adenophora tetraphylla, coptis chinensis, salviae miltiorrhizae, dendrobium, unprocessed rehmannia root, radix scrophulariae, rhizoma anemarrhenae, yam, fructus forsythiae and radices trichosanthis by the following steps: washing the components, mixing, decocting twice, filtering, concentrating, and combining the filtrates; concentrating to obtain extract, standing, taking supernate, and adding a honey and cane glucose mixture or a glycyrrhizin solution or a stevioside solution; adding sodium benzoate, boiling to dissolve; adding water, uniformly stirring, refrigerating and centrifugally separating the supernate; and performing ultrafiltration on the supernate by an ultrafiltration membrane, encapsulating the ultrafiltrate, and sterilizing. The concentrated oral solution is small in side effects, increased in concentration and content of effective ingredients, small in dosage and convenient to take and carry, and is suitable for patients who cannot decoct decoction or are difficult to take medicines.

The invention discloses a novel application of aescin and salt thereof in pharmacy, in particular relates to the novel application of aescin and salt thereof in preparing alpha-blocker medicaments and medicaments for treating chronic abacterial prostatitis. Pharmacodynamic experiment results indicate that aescin and salt thereof can be used for reducing the prostate organ coefficient of a rat model with chronic abacterial prostatitis caused by an estradiol benzoate injection, reducing the number of leukocytes in the prostate of the rat model with chronic abacterial prostatitis, and improving the density of the lecithin body in the prostate of the rat model. Clinical testing results indicate that the aescin and salt thereof can be used for relaxing prostate and bladder smooth muscle and have effects similar to alpha-blocker (bensylyt), the total effective rate of the aescin and salt thereof for treating chronic abacterial prostatitis is 88.33 percent, which is superior to that of the alpha-blocker bensylyt, and no remarkable adverse response is found.